About the Authors
- Nicholas M. Durham
-
Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
- Christopher J. Nirschl
-
Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
- Christopher M. Jackson
-
Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
- Jimmy Elias
-
Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
- Christina M. Kochel
-
Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
- Robert A. Anders
-
Affiliations Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
- Charles G. Drake
-
* E-mail: cdrake@jhmi.edu
Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
Competing Interests
CGD has served as a paid consultant for Bristol Myers Squibb, Compugen and Roche/Genentech. CGD is a co-inventor on a patent entitled: “Manipulation of Regulatory T Cells Using LAG-3 Antibodies, Genes, Agonists and Antagonists”, filing case number: C04255. This patent is currently un-licensed. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: NMD CJN CGD. Performed the experiments: NMD CJN CMJ JE CMK RAA. Analyzed the data: NMD. Contributed reagents/materials/analysis tools: NMD. Wrote the paper: NMD CGD.